Stay updated on Atezolizumab with BCG in NMIBC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.

Latest updates to the Atezolizumab with BCG in NMIBC Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check21 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed description of a Phase Ib/II study on atezolizumab for bladder cancer, which included safety, dosing, and eligibility criteria. Additionally, a new revision number has been added, indicating an update to the document version.SummaryDifference27%
- Check64 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Atezolizumab with BCG in NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.